| |
 |
Editorial [Hot Topic: Perspectives of Pharmacokinetics and Metabolism in Drug Design (Executive Editor: Yunsheng Hsieh)]
|
| |
|
pp.2169-2169 (1) Author: Yunsheng Hsieh
|
| |
|
|
| |
|
Drug Metabolism and Pharmacokinetics in Support of Drug Design
|
| |
|
pp.2170-2183 (14) Authors: Wei Tang, Anthony Y.H. Lu
|
| |
|
|
| |
|
Drug-Like Property Concepts in Pharmaceutical Design
|
| |
|
pp.2184-2194 (11) Authors: Li Di, Edward H. Kerns, Guy T. Carter
|
| |
|
|
| |
|
Comprehensive Assessment of ADMET Risks in Drug Discovery
|
| |
|
pp.2195-2219 (25) Author: Jianling Wang
|
| |
|
|
| |
|
Metabolite Identification and Profiling in Drug Design: Current Practice and Future Directions
|
| |
|
pp.2220-2235 (16) Authors: Zhoupeng Zhang, Mingshe Zhu, Wei Tang
|
| |
|
|
| |
|
Current Prodrug Design for Drug Discovery
|
| |
|
pp.2236-2250 (15) Authors: Pei-Wen Hsieh, Chi-Feng Hung, Jia-You Fang
|
| |
|
|
| |
|
The Role of Hyphenated Chromatography-Mass Spectrometry Techniques in Exploratory Drug Metabolism and Pharmacokinetics
|
| |
|
pp.2251-2261 (11) Authors: Yunsheng Hsieh, Walter Korfmacher
|
| |
|
|
| |
|
The Role of Exploratory Drug Metabolism and Pharmacokinetics in New Drug Research: Case Study-Selection of a Thrombin Receptor Antagonist for Development
|
| |
|
pp.2262-2269 (8) Authors: Yunsheng Hsieh, K.-C. Cheng, Yuguang Wang, Samuel Chackalamannil, Yan Xia, Walter A. Korfmacher, Ronald E. White
|
| |
|
|
